Generated by Meeveem AI
"Advancing health science from discovery to cure with precision diagnostics and life sciences"
Revvity delivers health science solutions spanning life sciences and diagnostics. The company provides technologies and services supporting workflows from drug discovery through disease diagnosis. Its portfolio includes screening platforms, imaging systems, bioanalytical instruments, informatics software, and molecular diagnostics for pharmaceutical companies, clinical laboratories, and healthcare facilities. The company addresses healthcare challenges in reproductive health, newborn screening, autoimmune diagnostics, and infectious disease testing. With technologies protecting over 33 million babies annually and analyzing more than 85 million blood samples worldwide, Revvity accelerates the path from scientific discovery to clinical care.
11000
Team Members
1937
Founded
Diagnostics
Sector
Hybrid
Work Environment
A world where scientific discovery flows seamlessly to clinical cure, where diseases are diagnosed at their earliest stages, where treatments emerge faster, and where precision healthcare transforms every patient outcome across the globe.
Expands the boundaries of human potential through science by diagnosing diseases earlier, developing treatments and cures sooner, and forging new pathways faster with precision and quality.